The Drugs Regulatory Authority of Pakistan (DRAP) had issued a notification revoking the earlier decision of allowing the pharmaceutical firms to raise the prices of medicines from 10 to 15 percent. A new price list of different brands manufactured by the national and multinational firms was also provided to the medicines’ manufacturers and distributors. But only one multinational pharmaceutical company “Bayer” lowered the prices of its products whereas other national and multinational companies and their distributers threw the DRAP notification and revised price list to the dust bin and are charging high prices of life saving drugs being used by patients as regular items of outdoor treatment for their whole life.
The multinational company that manufactures insulation injections has raised the price of Hymulin (R) from Rs.640 to Rs. 890. The same company also produces Hymulin 70/30 and may jack up its price abnormally as well. The available data on type-1 and type-2 diabetes reveal that 26 percent people in the country are diabetic, majority of whom are on different preparations of insulin injections plus Solstar injection. The 42 percent increase in the price of insulin will further compound the financial woes of diabetic patients. Moreover, the pharmaceutical companies charge exorbitantly high prices of medicines that heart and blood pressure patients regularly use. The DRAP authorities and Drug Inspectors of Provincial Health Department must not play the role of spectators at the cost of the precious lives of the people and implement the instructions about lowering of medicines’ price in addition to taking strong action against the arbitrary increase of 40 plus percent in the price of Insulin injections.
The post Arbitrary increase in medicines’ price appeared first on The Frontier Post.
from The Frontier Post https://ift.tt/2YeyEbD
No comments:
Post a Comment